Jalra M 50+500 mg is the combination of Vildagliptin and Metformin used to treat patients with type 2 diabetes whose condition can’t be controlled by diet and exercise alone. Both medicines work together to help control blood glucose levels. This medication is also known as oral antidiabetics. The exact mechanism of action of this combination antidiabetic agent is not known, but it has been shown to reduce glucose absorption from the gastrointestinal tract, reduce glucogenesis, and enhance insulin sensitivity by increasing peripheral glucose uptake and utilization.